IBRX Stock Sees Sharp UAE-Driven Jump Followed By Early August Pullback
On July 29, UAE regulators approved ImmunityBio’s main cancer drug ANKTIVA for two indications, sparking a rally the next day. The stock, however, slipped in the regular session on Friday and Monday. Wall Street, on average, expects the company to report …